1. Comparative efficacy and safety and dolutegravir and lamivudine in treatment naive HIV patients. (1st September 2019) Authors: Radford, Matthew; Parks, Daniel C.; Ferrante, Shannon; Punekar, Yogesh Journal: AIDS Issue: Volume 33:Number 11(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0189 POOLED ANALYSIS OF THE REAL-WORLD EFFECTIVENESS OF BELIMUMAB IN TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS USING MULTI-COUNTRY DATA FROM THE OBSERVE STUDIES. (June 2019) Authors: Collins, Christopher; Cortés-Hernández, Josefina; García, Mercedes; Kempis, Johannes von; Schwarting, Andreas; Touma, Zahi; Ferrante, Shannon; Kurtinecz, Milena; Gairy, Kerry Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 771 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Incidence of corneal adverse events in patients with multiple myeloma and their clinical and economic impact: A real-world retrospective cohort study. (31st December 2022) Authors: Wang, Feng; Sansbury, Leah; Ferrante, Shannon; Maiese, Eric M.; Willson, Jenny; Chen, Chi-Chang; Nunna, Sasikiran; Sun, Kainan; Kleinman, David M. Journal: Journal of medical economics Issue: Volume 25:Number 1(2022) Page Start: 182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Treatment patterns and overall survival of patients with double-class and triple-class refractory multiple myeloma: a US electronic health record database study. Issue 2 (28th January 2023) Authors: Wang, Peter Feng; Yee, Christopher W.; Gorsh, Boris; Zichlin, Miriam L.; Paka, Prani; Bhak, Rachel H.; Boytsov, Natalie; Khanal, Anamika; Noman, Ahmed; DerSarkissian, Maral; Ferrante, Shannon; Duh, Mei Sheng Journal: Leukemia & lymphoma Issue: Volume 64:Issue 2(2023) Page Start: 398 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗